欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/V/0188/001
药品名称
Finilac 50 mcg/ml
活性成分
cabergoline 50.0 µg/ml
剂型
Oral solution
上市许可持有人
Le Vet. Beheer B.V.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Denmark (DK)
Belgium (BE)
Finilac 50 µg/ml
Luxembourg (LU)
Iceland (IS)
Finilac 50 míkróg/ml Mixtúra, lausn handa hundum og köttum
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Finilac Oral solution 50µg/ml
Austria (AT)
Finilac 50 Mikrogramm/ml Lösung zum Eingeben für Hunde und Katzen
France (FR)
FINILAC 50 µG/ML
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Sweden (SE)
Norway (NO)
Finland (FI)
Poland (PL)
Latvia (LV)
Finilac vet
Lithuania (LT)
Estonia (EE)
Finilac vet
Hungary (HU)
Cyprus (CY)
Czechia (CZ)
Finilac 50 μg/ml perorální roztok pro psy a kočky
Romania (RO)
Slovakia (SK)
Slovenia (SI)
Croatia (HR)
许可日期
2014/12/16
最近更新日期
2024/08/12
药物ATC编码
QG02CB03 cabergoline
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
1b_label_leaflet_cabergoline_clean_v5
Date of last change:2024/09/06
Final SPC
|
1b_spc_cabergoline_clean_v5
Date of last change:2024/09/06
PubAR
|
PuAR Finilac REG NL 114987
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase